CUSTOPHARM
CUSTOpharm is a customer-focused service company that provides personalized cost-effective chemistry and manufacturing controls (CMC) and regulatory support to companies with limited resources and those seeking to expand into new areas. CUSTOpharm has a strong background in product development (developed 54 sterile products to date, 48injectable products, 2 nasal products, 2 oral products, and 2 sterile ophthalmics), manufacturing, and regulatory affairs (specifically as it relates to electro... nic submissions). CUSTOpharm filed the first eCTD ANDA with the FDA in 2004, have filed over 170 ANDA's since. This background allows us to visualize the "big picture" of their clients' projects with a marketable finished product as the ultimate goal. This "big picture" approach places CUSTOpharm ahead of other competitors, which focus on specific tasks, not the finished product.
CUSTOPHARM
Industry:
Biotechnology Health Care Manufacturing Medical
Founded:
2005-01-01
Address:
Carlsbad, California, United States
Country:
United States
Website Url:
http://www.custopharm.com
Total Employee:
11+
Status:
Active
Contact:
760-683-0901
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Font Awesome Wordpress Plugins Nginx Microsoft Exchange Online
Current Employees Featured
Founder
Investors List
Water Street Healthcare Partners
Water Street Healthcare Partners investment in Private Equity Round - Custopharm
Official Site Inspections
http://www.custopharm.com Semrush global rank: 6.6 M Semrush visits lastest month: 935
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Custopharm"
Custopharm - Crunchbase Company Profile & Funding
CUSTOpharm is a customer-focused service company that provides personalized cost-effective chemistry and manufacturing controls (CMC) and regulatory support to companies with limited …See details»
Hikma completes acquisition of Custopharm
Apr 21, 2022 Hikma completes acquisition of Custopharm London, 21 April 2022 – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces …See details»
Custopharm Company Profile | Management and Employees List
Custopharm is a leader in the generic injectables market. Its goal is to provide important new generic injectable products to the acute and specialty markets and to reach people and …See details»
Hikma strengthens US Injectables business through acquisition of …
Custopharm invests significantly in developing and acquiring new products, including through strategic partnerships. It also launches newly approved products through its nationally …See details»
Custopharm - Overview, News & Similar companies | ZoomInfo.com
Custopharm is a leader in the generic injectables market. ... It also launches newly approved products through its nationally recognized commercial organization, Leucadia …See details»
Custopharm - Products, Competitors, Financials, Employees, …
Custopharm is a customer-focused service company that provides personalized cost-effective chemistry and manufacturing controls (CMC) and regulatory support to companies with limited …See details»
Hikma strengthens US Injectables business through acquisition of …
Sep 27, 2021 Hikma strengthens US Injectables business through acquisition of Custopharm London, 27 September 2021 – Hikma Pharmaceuticals PLC (Hikma), the multinational …See details»
Custopharm Company Profile 2024: Valuation, …
Custopharm General Information Description. Developer of complex sterile injectable generic products. The company sources difficult-to-obtain raw materials, solves formulation and analytical challenges and writes and …See details»
Hikma Pharmaceuticals acquires Custopharm - 2021-09-27
Apr 21, 2022 Custopharm Custopharm is a customer-focused service company that provides personalized cost-effective chemistry and manufacturing controls. Acquiring Organization: …See details»
Custopharm Company Profile - Office Locations, Competitors
See insights on Custopharm including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Water Street Completes Sale of Custopharm
April 20, 2022 Water Street Completes Sale of Custopharm. Chicago — Water Street Healthcare Partners announced today that it has completed the sale of its generic pharmaceutical …See details»
Custopharm - Company Profile & Staff Directory - ContactOut
CUSTOpharm is a customer-focused service company that provides personalized cost-effective chemistry and manufacturing controls (CMC) and regulatory support to companies with limited …See details»
Custopharm - M&A Summary, Ownership, and Business Overview
Sep 27, 2021 Custopharm is a generic injectable drug services company. The company specializes in developing a range of generic injectable products, including those with complex …See details»
Hikma completes acquisition of Custopharm
Apr 20, 2022 Hikma completes acquisition of Custopharm Combination expands US Injectables portfolio and pipeline Press Release London, 21 April 2022 –Hikma Pharmaceuticals PLC …See details»
Custopharm - Contacts, Employees, Board Members, Advisors
Custopharm is a customer-focused service company that provides personalized cost-effective chemistry and manufacturing controls. Search Crunchbase. Start Free Trial . Chrome …See details»
Hikma strengthens US Injectables business through acquisition of …
Sep 27, 2021 William C. Larkins, Ph.D., CEO of Custopharm and Leucadia, added: "We're excited to become part of Hikma, a global leader that shares our deep commitment to bringing …See details»
Hikma Pharmaceuticals Signs Agreement with Water Street to …
September 27, 2021 Hikma Pharmaceuticals Signs Agreement with Water Street to Acquire Custopharm. London — Hikma Pharmaceuticals PLC (Hikma), the multinational …See details»
Continued strategic progress and updated full year guidance
Apr 29, 2022 Our acquisition of Custopharm, which closed last week, enhances our R&D capabilities and pipeline while further expanding our portfolio of differentiated injectable …See details»
Hikma Pharma To Buy Generic Sterile Injectables Firm Custopharm ...
Sep 27, 2021 Custopharm is a growing business and Hikma expects it to generate full year 2021 revenue in excess of $80 million and for the acquisition to be accretive to Hikma's Injectables …See details»
Hikma confirms FTC preliminary approval for Custopharm
London, 20 April 2022 – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today confirms it has received preliminary approval from the US …See details»